Award
National Cancer Institute 5R01CA285415-03
Identification of Covalent Transcriptional Dependencies in Melanoma
Recipient
Massachusetts General Hospital
Award Amount
$668,695.00
Ceiling
$668,695.00
Awarded
May 19, 2026
Identifier
5R01CA285415-03
NIH grant awarded by the National Cancer Institute for research on covalent transcriptional dependencies in melanoma, focusing on SOX10 targeting using chemical-proteomic and genomic technologies.
Description
The project involves advanced chemical-proteomic and genomic technologies to understand the mode of action of covalent ligands targeting SOX10 in melanoma. The grant is managed by the Massachusetts General Hospital in Boston.